Latest news and events
Latest News from the Partnership
2021.07.06 | Research news
Developing better therapies for rare immune diseases
Dr Emma Haapaniemi is head of the Precision Pediatrics and Gene Editing group at NCMM. Here, she describes the impacts and burden that rare immune diseases have on patients and how she is working to help provide them with a cure.
2021.06.15 | People
Keisuke Yonehara: How experience gained at DANDRITE helped him secure a permanent professorship in Japan
Keisuke Yonehara is head of the Spatially Asymmetric Neural Circuits in Visual System group at DANDRITE
2021.06.11 | People
NCMM opens new call for group leaders
The Centre is seeking 2-3 new group leaders in AI/Machine Learning and Cell-based Approaches
2021.06.10 | Awards
Professor Poul Nissen, Director of DANDRITE, receives the Anders Jahre Senior Medical Prize 2021
Prof. Nissen recognised for his ground-breaking research into the structure and function of membrane proteins.
2021.06.08 | Research news
MIMS and FIMM collaboration: Stress responses in cross-microbial species are disclosed
The Fällman group has published a new article in Nature Communications with the title: “RNA atlas of human bacterial pathogens uncovers stress dynamics linked to infection”. The project involved collaboration with researchers at FIMM/University of Helsinki.
2021.05.12 | Research news
Johan Lundin: How AI can help in a healthcare setting
Professor Johan Lundin is a Research Director at FIMM (Institute for Molecular Medicine Finland), University of Helsinki. He is also a Professor of Medical Technology at the Karolinska Institutet. His research specializes in developing and studying technologies to aid diagnostics at the point of care, in particular in research-limited countries.…
2021.05.11 | Research news
Latest public release of FinnGen data
FinnGen, which is coordinated by researchers at Nordic EMBL node FIMM, is excited to announce that the FinnGen data freeze 5 results and summary statistics are now publicly available.
2021.05.04 | News from the management
Launch of Danemo: A new initiative to promote the opportunities at EMBL and EMBO
The establishment of DANEMO is designed to help strengthen the Danish life sciences and biophysics
2021.04.23 | Research news
Malaria researchers at MIMS, Ellen Bushell and Oliver Billker, reflect on World Malaria Day (25 April)
During the World Health Assembly in 2007, the World Health Organization (WHO) Member States established 25th April as World Malaria Day. Fourteen years have passed, and malaria is still a global threat, claiming over 400, 000 lives every year, mostly killing children under 5 according to the WHO.
2021.04.20 | People
Three NCMM research groups extended for a further four years
Following a successful evaluation by NCMM’s Scientific Advisory Board (SAB), the NCMM Board has decided to extend the groups of Irep Gözen, Nikolina Sekulic, and Anthony Mathelier
Upcoming Partnership Events
- Mon 08 Nov
- 10:50-10:50 | Oslo
PhD Course in Molecular Medicine
NCMM will organise their annual PhD course in Molecular Medicine. The event runs for two weeks. - Wed 01 Dec
- 10:56-10:56 | FIMM/University of Helsinki, Finland
FIMM Building Bridges 2021
'From Research Infrastructure to Clinical Translation' - Mon 31 Jan
- 12:06-12:06 | Aarhus
Annual Nordic EMBL Partnership Network Meeting
Hosted by DANDRITE. Further details to follow.
News on publications
2021.06.08 | Publication
RNA atlas of human bacterial pathogens uncovers stress dynamics linked to infection
Bacterial pathogens have to cope with stressful environments in human host. Their response with the activity of gene products enables them to adapt to those stressful environments and cause troublesome infections. Therefore, genes involved in the adaptation are potential targets for new antimicrobials.
2021.02.01 | Publication
Cryo-EM structure of Helicobacter pylori urease with an inhibitor in the active site at 2.0 Å resolution
The Luecke Group at NCMM have published in the journal Nature Communications
2021.02.01 | Publication
Binocular integration of retinal motion information underlies optic flow processing by the cortex
Rune Nguyen Rasmussen and Akihiro Matsumoto et al. from Keisuke Yonehara’s lab have published in Current Biology.
2020.11.26 | Publication
Biological lipid nanotubes and their potential role in evolution
Research from the Gözen group at NCMM published in The European Physical Journal Special Topics.
2020.09.10 | Publication
New publication from MIMS group leader Björn O. Schröder in JBC on function of microbiota in obese mice
The paper, 'Obesity-associated microbiota contributes to mucus layer defects in genetically obese mice', has been published in the Journal of Biological Chemistry.
2020.09.10 | Publication
A high profile review article from MIMS group leader Barbara S. Sixt on host cell death modulation by the bacterial pathogen Chlamydia
The review has been published in the journal FEMS Microbiology Reviews.
2020.09.02 | Research news, Publication
Comment article: Predicting Cancer Evolution Using Cell State Dynamics
Dr Kuijjer's article, 'Predicting Evolution Using Cell State Dynamics', examines research using state transitions to model cancer development and progression.
2020.09.02 | Publication
Rapid Growth and Fusion of Protocells in Surface‐Adhered Membrane Networks
Elevated temperatures might have promoted the nucleation, growth, and replication of protocells on the early Earth.
2020.05.14 | Knowledge exchange, Publication
Joint efforts between Nabavi and Capogna group have led to the development of a novel approach named TRACE ´Tracing Retrogradely the Activated Cell Ensemble’
The neural circuitry teams at DANDRITE and PROMEMO introduce a novel approach in their latest publication, which selectively labels sensory inputs that are activated by a defined stimulus and directed to a region of interest in the brain.
2020.05.06 | Publication, Knowledge exchange
Gene variants that protect against glaucoma identified, opening therapeutic possibilities
An international research collaboration led by researchers from the University of Helsinki and Stanford University has identified rare changes in a gene called ANGPTL7 that lower intraocular pressure and significantly reduce the risk of glaucoma. The results open important new therapeutic possibilities.
